Merck KGaA (OTCMKTS:MKKGY) Sees Significant Increase in Short Interest

Merck KGaA (OTCMKTS:MKKGY) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 184,605 shares, a growth of 84.3% from the December 31st total of 100,145 shares. Based on an average daily volume of 158,067 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.0% of the shares of the company are sold short. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 158,067 shares, the days-to-cover ratio is currently 1.2 days.

Merck KGaA Price Performance

Merck KGaA stock opened at $30.31 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.49 and a quick ratio of 0.97. The business has a 50 day simple moving average of $28.65 and a 200-day simple moving average of $26.95. Merck KGaA has a 12 month low of $24.32 and a 12 month high of $31.80. The stock has a market capitalization of $19.59 billion, a PE ratio of 12.08, a price-to-earnings-growth ratio of 6.16 and a beta of 0.95.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings data on Thursday, November 13th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.27. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. The company had revenue of $6.17 billion for the quarter, compared to analysts’ expectations of $6.08 billion. Equities analysts predict that Merck KGaA will post 1.87 earnings per share for the current year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.